NOVELIX [NOVELIX] vs Entero Healthcare [ENTERO] Detailed Stock Comparison

NOVELIX

BSE
Loading...

Entero Healthcare

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: NOVELIX wins in 6 metrics, Entero Healthcare wins in 12 metrics, with 0 ties. Entero Healthcare appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricNOVELIXEntero HealthcareBetter
P/E Ratio (TTM)65.5748.24Entero Healthcare
Price-to-Book Ratio2.272.86NOVELIX
Debt-to-Equity Ratio0.0021.76NOVELIX
PEG Ratio-0.541.26NOVELIX
EV/EBITDA59.1325.34Entero Healthcare
Profit Margin (TTM)1.04%1.90%Entero Healthcare
Operating Margin (TTM)0.76%2.94%Entero Healthcare
EBITDA Margin (TTM)0.76%2.94%Entero Healthcare
Return on Equity0.48%5.36%Entero Healthcare
Return on Assets (TTM)0.31%3.51%Entero Healthcare
Free Cash Flow (TTM)$-137.91M$-881.80MNOVELIX
1-Year Return50.92%-13.53%NOVELIX
Price-to-Sales Ratio (TTM)1.100.91Entero Healthcare
Enterprise Value$457.83M$49.37BEntero Healthcare
EV/Revenue Ratio0.870.91NOVELIX
Gross Profit Margin (TTM)2.56%9.94%Entero Healthcare
Revenue per Share (TTM)$48$1,242Entero Healthcare
Earnings per Share (Diluted)$0.61$23.51Entero Healthcare
Beta (Stock Volatility)0.28N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

NOVELIX vs Entero Healthcare Stock Performance Analysis

Loading Price Chart...

NOVELIX
Entero Healthcare
NOVELIX Stock Overview | Entero Healthcare Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
NOVELIX-0.40%-3.21%0.15%-13.62%50.92%50.92%
Entero Healthcare-0.40%3.19%-3.55%-5.33%0.08%-21.46%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
NOVELIX50.92%50.92%50.92%50.92%50.92%50.92%
Entero Healthcare-13.53%-1.92%-1.92%-1.92%-1.92%-1.92%

News Based Sentiment: NOVELIX vs Entero Healthcare

NOVELIX

News based Sentiment: MIXED

October saw significant price fluctuations for Novelix Pharmaceuticals, alongside mixed financial results (revenue growth but net loss) and a positive analyst rating. These developments create a mixed investment picture, suggesting both potential and risk for investors.

View NOVELIX News Sentiment Analysis

Entero Healthcare

News based Sentiment: MIXED

October presented a mixed bag for Entero Healthcare Solutions, with positive price movements and analyst upgrades offset by continued volatility, a 52-week low, and a recent divestiture. The company is clearly in a period of change, making this a significant month for investors to assess its future direction.

View Entero Healthcare News Sentiment Analysis

Performance & Financial Health Analysis: NOVELIX vs Entero Healthcare

MetricNOVELIXENTERO
Market Information
Market Cap i₹595.80M₹49.35B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,851197,998
90 Day Avg. Volume i4,037136,874
Last Close₹40.00₹1,123.00
52 Week Range₹24.15 - ₹52.79₹1,044.90 - ₹1,584.25
% from 52W High-24.23%-29.11%
All-Time High₹52.79 (Jul 15, 2025)₹1,584.25 (Nov 04, 2024)
% from All-Time High-24.23%-29.11%
Growth Metrics
Quarterly Revenue Growth30.98%0.28%
Quarterly Earnings Growth36.18%0.38%
Financial Health
Profit Margin (TTM) i0.01%0.02%
Operating Margin (TTM) i0.01%0.03%
Return on Equity (TTM) i0.00%0.05%
Debt to Equity (MRQ) i0.0021.76
Cash & Liquidity
Book Value per Share (MRQ)₹17.59₹396.70
Cash per Share (MRQ)₹0.57₹73.09
Operating Cash Flow (TTM) i₹-221,349,560₹-1,784,990,000
Levered Free Cash Flow (TTM) i₹845,200₹948.20M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: NOVELIX vs Entero Healthcare

MetricNOVELIXENTERO
Price Ratios
P/E Ratio (TTM) i65.5748.24
Forward P/E iN/A22.17
PEG Ratio i-0.541.26
Price to Sales (TTM) i1.100.91
Price to Book (MRQ) i2.272.86
Market Capitalization
Market Capitalization i₹595.80M₹49.35B
Enterprise Value i₹457.83M₹49.37B
Enterprise Value Metrics
Enterprise to Revenue i0.870.91
Enterprise to EBITDA i59.1325.34
Risk & Other Metrics
Beta i0.28N/A
Book Value per Share (MRQ) i₹17.59₹396.70

Financial Statements Comparison: NOVELIX vs Entero Healthcare

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NOVELIXENTERO
Revenue/Sales i₹223.51M₹14.04B
Cost of Goods Sold i₹217.79M₹12.64B
Gross Profit i₹5.73M₹1.40B
Research & Development iN/AN/A
Operating Income (EBIT) i₹1.69M₹412.02M
EBITDA i₹1.80M₹558.96M
Pre-Tax Income i₹1.69M₹363.63M
Income Tax i₹624,000₹61.31M
Net Income (Profit) i₹1.07M₹302.32M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NOVELIXENTERO
Cash & Equivalents i₹6.79M₹2.29B
Total Current Assets i₹269.33M₹20.76B
Total Current Liabilities i₹96.67M₹8.45B
Long-Term Debt i₹0₹670.18M
Total Shareholders Equity i₹175.39M₹17.70B
Retained Earnings i₹-18.76M₹638.28M
Property, Plant & Equipment i₹1.86M₹1.64B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NOVELIXENTERO
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNOVELIXENTERO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i2,851197,998
Average Daily Volume (90 Day) i4,037136,874
Shares Outstanding i9.95M43.51M
Float Shares i3.12M11.24M
% Held by Insiders i0.82%0.63%
% Held by Institutions i0.00%0.20%

Dividend Analysis & Yield Comparison: NOVELIX vs Entero Healthcare

MetricNOVELIXENTERO
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A